Advertisement

Topics

Residex Ventures B.V. Company Profile

05:17 EDT 22nd September 2018 | BioPortfolio

Residex Ventures provides capital and expertise to accelerate market traction for technology companies. The focus is private equity from start-up to pre-listing phases of innovative European and North American companies. Residex Ventures is currently setting up their third fund and has two funds under management.

Location

Kosterijland 70-78
Bunnik
3981 AJ
Netherlands

Contact

Phone: 31 (0) 30-659 55 00
Fax: 31 (0) 30-659 55 11
Email: info@residexventures.com


News Articles [351 Associated News Articles listed on BioPortfolio]

League raises fresh capital to grow employee health benefits platform

The Canadian startup secured C$62 million (or about $47.5 million) in a round led by TELUS Ventures. Wittington Ventures, OMERS, RBC Ventures, Real Ventures, Infinite Potential Group and BDC IT Ventu...

RubiconMD wraps up $13.8M Series B to connect PCPs and specialists

The round, which was led by HLM Ventures and Optum Ventures, included participation from Centene Corporation, Alma Mundi Ventures and others.

Eko raises $5mm in Series A round

Eko (cardiac monitoring devices) raised $5mm in its Series A financing led by ARTIS Ventures, which was joined by Strategic Partners, Dreamlt Ventures, 1812 Ventures, and founder.org.

StrideBio gets $15.7mm via Series A

StrideBio Inc. (developing novel adeno-associated viral (AAV) vectors for in vivo gene therapies aimed at rare diseases) raised $15.7mm in an oversubscribed Series A financing led by Hatteras Venture ...

AI firm Atomwise secures $45mm Series A round

Atomwise Inc. (AI using deep neural networks for drug discovery) closed a $45mm Series A round co-led by Monsanto Growth Ventures, DCVC (Data Collective), and B Capital Group. Returning backers Y Comb...

Brain-machine interface start-up Paradromics brings in $7mm in seed funding

Paradromics Inc. (implantable brain-machine interface (BMI) technology) brought in $7mm in a seed financing round co-led by Arkitekt Ventures (adds a board member) and Synergy Ventures. It-Farm, Dolby...

Mental health startup SonderMind brings in $2.5M seed round

Kickstart Seed Fund led the round, and Purple Arch Ventures, SpringTime Ventures, Service Provider Capital and Lanoha Ventures also participated.

Series E round brings $85.4mm to Sutro Biopharma

Sutro Biopharma Inc. (oncology) raised $85.4mm through its Series E round. Samsara BioCapital and Surveyor Capital co-led and were joined by existing backers Alta Partners, Amgen Ventures, Celgene, Li...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Avant ex [B4 Ventures LLC]

B4 Brands: Avant EX Instant Hand Sanitizer

Avant foaming hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free

Avant original instant hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Original Instant Hand Sanitizer

Aterra antibacterial hand wash [B4 Ventures LLC]

B4 Brands: Aterra Antibacterial Hand Soap

Avant original - fragrance free [B4 Ventures LLC]

B4 Brands: Avant Original - Fragrance Free Instant Hand Sanitizer

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Outsourcing of Academic Clinical Laboratories: Experiences and Lessons From the Association of Pathology Chairs Laboratory Outsourcing Survey.

American hospitals are increasingly turning to service outsourcing to reduce costs, including laboratory services. Studies of this practice have largely focused on nonacademic medical centers. In cont...

Estimating and valuing the carbon release in scenarios of land-use and climate changes in a Brazilian coastal area.

Deforestation is a significant source of man-made carbon in the atmosphere, contributing to the greenhouse gas (GHG) effect. Although carbon releases are associated to the ecosystem functions of clima...

"Yes, we know!" (Over)confidence in general knowledge among Austrian entrepreneurs.

Overconfidence has been reported to be a common bias among entrepreneurs and might be one cause of the high failure rates observed for new ventures. In this study, we investigate the overconfidence bi...

The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.

It is evidenced that 20% of all tumors in humans are caused by oncoviruses including Human Papilloma Viruses (HPV), Epstein-Barr Virus (EBV), Kaposi Sarcoma Virus (KSHV), Human Polyomaviruses (HPyV), ...

Detecting opinion spams through supervised boosting approach.

Product reviews are the individual's opinions, judgement or belief about a certain product or service provided by certain companies. Such reviews serve as guides for these companies to plan and monito...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Evaluation of a Digital Microscope for Malaria

Light microscopy, which is based on century-old technology, remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalaria...

Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)

Microscopy remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalarials or in the context of regulatory clinical trial...

Companies [549 Associated Companies listed on BioPortfolio]

Residex Ventures B.V.

Residex Ventures provides capital and expertise to accelerate market traction for technology companies. The focus is private equity from start-up to pre-listing phases of innovative European and North...

GE Ventures

GE Ventures is committed to identifying, scaling and accelerating ideas that will make the world work better. Focused on the areas of software, advanced manufacturing, energy and ...

Extraordinary Ventures, Inc.

Founded in 2007 by a group of concerned parents, Extraordinary Ventures (EV) is a 501(c)(3) enterprise that creates and operates a portfolio of self-sustaining small, local busine...

Archytas Ventures, LLC

Archytas Ventures is a private, opportunistic investment holding company with offices in New York and Los Angeles. Archytas Ventures provides strategic capital solutions to the em...

Jina Ventures

Founded in 2003, Jina Ventures is a New York-based private equity and M&A advisory firm. Over the past 6 years, Jina Ventures has grown into a full service private equity practice, with both principal...

More Information about "Residex Ventures B.V." on BioPortfolio

We have published hundreds of Residex Ventures B.V. news stories on BioPortfolio along with dozens of Residex Ventures B.V. Clinical Trials and PubMed Articles about Residex Ventures B.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Residex Ventures B.V. Companies in our database. You can also find out about relevant Residex Ventures B.V. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record